跳至主要内容
临床试验/PACTR2008060000852767
PACTR2008060000852767Other未知

Doubling The Dose Of Lopinavir/Ritonavir As An Approach To Using Kaletra® In TB/HIV-infected Patients Receiving Rifampicin-based TB Treatment

niversity of Cape Town0 个研究点目标入组 0 人开始时间: 2008年2月8日最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • HIV-infected children with and without TB (controls) aged 6 months to 15 years.
  • Children eligible for, or, established on protease inhibitor-
  • based HAART according to National Treatment Guidelines

排除标准

  • ALT > 10X the upper limit of normal (grade 3 or 4).
  • Known renal, hepatic or chronic GIT disease.
  • Receiving drugs other than the study medication known to potently induce or inhibit CYP3A4 or alter the PK of LPV.

研究者

发起方
niversity of Cape Town

相似试验

进行中(未招募)
不适用
A randomised, single-dose, dose ascending, double-blind, placebo controlled, four-way, incomplete block crossover study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled doses of GW642444M with magnesium stearate in COPD patientsCOPD patients (moderate)
EUCTR2007-001391-37-DEGlaxoSmithKline Research & Development Limited20
已完成
3 期
A double-blind, placebo-controlled, dose-escalation, parallel-group study to evaluate the efficacy and safety of E2007 (perampanel) given as adjunctive therapy in subjects with refractory partial seizures.epilepsy
NL-OMON35288Eisai50
招募中
不适用
ShorT spAce or incRease dosage of Biologics for rheumatoid arthritis patients with subclinical synOvitis detected by ultrAsound suppRess joint DestructioRheumatoid Arthritis
JPRN-UMIN000036601Osaka city university, School of medicine100
进行中(未招募)
不适用
A Double-blind, Placebo-controlled, Dose-escalation, Parallel Group Study of E2007 given as Adjunctive Therapy in Patients with Refractory Partial SeizuresE2007 is given as adjunctive therapy in patients with refractory partial seizuresMedDRA version: 9.1Level: LLTClassification code 10061334Term: Partial seizures
EUCTR2005-004199-18-LTEisai Limited144
进行中(未招募)
不适用
A Double-blind, Placebo-controlled, Dose-escalation, Parallel Group Study of E2007 given as Adjunctive Therapy in Patients with Refractory Partial SeizuresE2007 is given as adjunctive therapy in patients with refractory partial seizures
EUCTR2005-004199-18-SEEisai Limited144